Intravitreal Anti–Vascular Endothelial Growth Factor Treatment and the Risk of Thromboembolism
Purpose To evaluate the subsequent risk of thromboembolic events in patients receiving intravitreal ranibizumab and bevacizumab for age-related macular degeneration or macular edema. Design Population-based crossover analysis with self-matched historical…